FDA Approves First Twice-Yearly Antipsychotic for Schizophrenia ...Middle East

Medscape - News
The FDA has approved a 6-month injection form of the long-acting atypical antipsychotic paliperidone palmitate (Invega Hafyera) for adults with schizophrenia. FDA Approvals

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves First Twice-Yearly Antipsychotic for Schizophrenia )

Also on site :



Latest News